Altamira Therapeutics Ltd. (CYTOF)
OTCMKTS
· Delayed Price · Currency is USD
0.1000
0.00 (0.00%)
Apr 28, 2025, 4:00 PM EDT
Altamira Therapeutics Employees
Altamira Therapeutics had 10 employees as of December 31, 2023. The number of employees decreased by 6 or -36.20% compared to the previous year.
Employees
10
Change (1Y)
-6
Growth (1Y)
-36.20%
Revenue / Employee
n/a
Profits / Employee
-$270,088
Market Cap
465.74K
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Endo Inc. | 3,116 |
Glass House Brands | 374 |
Elite Pharmaceuticals | 64 |
Northwest Biotherapeutics | 25 |
CytoDyn | 9 |
American Oncology Network | 1,914 |
Silence Therapeutics | 116 |
Longduoduo Company | 49 |
Altamira Therapeutics News
- 4 days ago - Altamira Therapeutics to Host Full Year 2024 Financial Results and Business Update Call on April 30, 2025 - GlobeNewsWire
- 7 weeks ago - Altamira Announces Notice of Allowance from USPTO for Bentrio Nasal Spray Patent - GlobeNewsWire
- 4 months ago - Altamira Therapeutics Announces Successful Nanoparticle-Based Delivery of Circular RNA - GlobeNewsWire
- 4 months ago - Altamira Therapeutics Announces Transition from NASDAQ to OTC Markets - GlobeNewsWire
- 7 months ago - Altamira Therapeutics Provides Update on Nasdaq Listing - GlobeNewsWire
- 7 months ago - Altamira Therapeutics Announces Extended ISO 13485 Quality Management System Certification for Bentrio Nasal Spray - GlobeNewsWire
- 7 months ago - Altamira Therapeutics Ltd. (CYTO) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 7 months ago - Altamira Therapeutics Provides Business Update and First Half 2024 Financial Results - GlobeNewsWire